Insulet (PODD) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Insulet Corporation  (NASDAQ: PODD)
 

Insulet Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Insulet Corporation inventory turnover ratio, the Insulet Corporation's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 1.86 in the first quarter 2026, yet the ratio remained below the average, as PODD's market remain challenging.Average inventory processing period, for the Insulet in Mar 31 2026 quarter, has decreased to 196 days, compare to 212 days, in the Dec 31 2025 quarter.

Within Healthcare sector 220 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1200 in the fourth quarter 2025, to 1392.

PODD Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Insulet Corporation Market Share?

What is Inventory Turnover Ratio?




PODD Inventory Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 4.92 % 5.16 % 0.31 % 3.71 % 2.37 %
Y / Y Cost of Sales Growth 45.37 % 29.11 % 17.63 % 24.94 % 18.61 %
Inventory Turnover Ratio (TTM) 1.86 1.72 1.63 1.57 1.49
PODD's Total Ranking # 1392 # 1200 # 1054 # 912 # 1112
Average inventory processing period 196 212 224 233 245
Seq. Inventory Growth 2.19 % 1.41 % -0.13 % 1.38 % 2.42 %
Seq. Cost of Sales Growth 8.14 % 9.63 % -0.36 % 23.06 % -3.96 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 94
Healthcare Sector # 221
Overall Market # 1392

Inventory Turnover Ratio Statistics
High Average Low
17.94 5.9 1.26
(Dec 31 2013)   (Jun 30 2022)




Financial Statements
Insulet's Inventories $ 463 Millions Visit PODD's Balance sheet
Insulet's Cost of Revenues TTM $ 841 Millions Visit PODD's Income Statement
What are PODD's Sales? Visit PODD's Sales by Segment

Other Inventory Turnover Ratios
Insulet's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PODD's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PODD's Competitors
Inventory Turnover Ratio for PODD's Suppliers
Inventory Turnover Ratio for PODD's Customers

You may also want to know
PODD's Sales Growth Rates PODD's Pe Price to earnings ratio PODD's Receivables Turnover Ratio PODD's Stock Quote
PODD's Net Income Growth Rates PODD's Ps Price to Sales ratio PODD's Sales per Employee PODD's Asset Turnover Ratio
PODD's Net Margin PODD's Pb Price to Book ratio PODD's Financial Strength Ratios PODD's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Integrated Biopharma Inc  4.96 $ 45.000  Millions$ 9  Millions
Ufp Technologies Inc   4.95 $ 436.000  Millions$ 88  Millions
Polomar Health Services, Inc.  4.79 $ 0.642  Millions$ 0  Millions
Henry Schein Inc   4.70 $ 9,209.000  Millions$ 1,959  Millions
Bionexus Gene Lab Corp   4.70 $ 4.191  Millions$ 1  Millions
Medinotec Inc   4.69 $ 4.864  Millions$ 1  Millions
West Pharmaceutical Services Inc   4.68 $ 2,052.000  Millions$ 439  Millions
Scilex Holding Company  4.48 $ 14.462  Millions$ 3  Millions
Guardant Health Inc   4.41 $ 379.203  Millions$ 86  Millions
Idexx Laboratories Inc  4.38 $ 1,690.942  Millions$ 386  Millions
Envista Holdings Corporation  4.36 $ 1,267.000  Millions$ 290  Millions
Inotiv Inc   4.25 $ 175.895  Millions$ 41  Millions
Cryoport inc   4.23 $ 96.609  Millions$ 23  Millions
Teva Pharmaceutical Industries Limited  4.22 $ 8,317.000  Millions$ 1,971  Millions
Incyte Corporation  4.21 $ 403.465  Millions$ 96  Millions
Electromed Inc   4.16 $ 14.195  Millions$ 3  Millions
Vericel Corporation  4.15 $ 73.494  Millions$ 18  Millions
Sharps Technology Inc   4.12 $ 3.585  Millions$ 1  Millions
Coherus Oncology inc   4.11 $ 14.975  Millions$ 4  Millions
Novocure Limited  4.08 $ 167.287  Millions$ 41  Millions
Lifeward ltd   4.08 $ 13.275  Millions$ 3  Millions
Ge Healthcare Technologies Inc   4.04 $ 9,262.000  Millions$ 2,294  Millions
Koru Medical Systems Inc   3.99 $ 16.468  Millions$ 4  Millions
3m Company  3.94 $ 15,087.000  Millions$ 3,830  Millions
Iridex Corp  3.92 $ 32.247  Millions$ 8  Millions
Myomo Inc   3.88 $ 14.000  Millions$ 4  Millions
Elite Pharmaceuticals Inc   3.84 $ 71.976  Millions$ 19  Millions
Escalon Medical Corp   3.79 $ 6.698  Millions$ 2  Millions
Evolus Inc   3.71 $ 103.000  Millions$ 28  Millions
Abbvie Inc   3.70 $ 18,420.000  Millions$ 4,975  Millions

Date modified: 2026-08-29T17:16:02+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.